Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Acclarent closes $26mm Series D after pulling IPO

Executive Summary

Following last month's withdrawal of its IPO due to the financial climate, Acclarent (endoscopic surgical devices for chronic sinusitis) looked to venture investors again and raised $26mm through its Series D round. New backer Johnson & Johnson Development Corp. joined returning shareholders New Enterprise Associates, Delphi Ventures, Versant Ventures, and Meritech Capital Partners.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies